RIA
JAZZ icon

Regal Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Regal Investment Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,801
Closed -$320K – 535
2021
Q2 		$320K Buy
+1,801
New +$312K 0.03% 404
2015
Q1 		– Sell
-142
Closed -$23K – 1004
2014
Q4 		$23K Buy
142
+21
+17% +$3.49K 0.01% 509
2014
Q3 		$19K Sell
121
-119
-50% -$18.3K 0.01% 561
2014
Q2 		$35K Buy
240
+140
+140% +$19.4K 0.01% 446
2014
Q1 		$14K Hold
100
– – 0.01% 585
2013
Q4 		$13K Sell
100
-50
-33% -$5.17K 0.01% 541
2013
Q3 		$14K Buy
+150
New +$12.1K 0.01% 537

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Regal Investment Advisors's JAZZ Position: Q3 2021 in Review

Regal Investment Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 1,801 shares — an estimated $320K sold.

Regal Investment Advisors first reported a position in JAZZ in Q3 2013 and held it in 7 quarters. The position peaked at $320K in Q2 2021. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

  • Regal Investment Advisors reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Regal Investment Advisors sold 1,801 Jazz Pharmaceuticals shares in Q3 2021, an estimated $320K.
  • Regal Investment Advisors first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 7 quarters.
  • Regal Investment Advisors's Jazz Pharmaceuticals position peaked at $320K in Q2 2021.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Regal Investment Advisors's 13F filing for Q3 2021, filed 5 Nov 2021.